Operating Lease, Liability of Skye Bioscience, Inc. from 30 Sep 2021 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Skye Bioscience, Inc. quarterly Operating Lease, Liability in USD history and change rate from 30 Sep 2021 to 31 Dec 2024.
Skye Bioscience, Inc. Operating Lease, Liability for the quarter ending 31 Dec 2024 was $455,590, a 87% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Skye Bioscience, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$455,590	+$212,322	+87%	31 Dec 2024	10-K	20 Mar 2025	2024	FY
Q4 2023	$243,268	+$164,568	+209%	31 Dec 2023	10-K	20 Mar 2025	2024	FY
Q3 2023	$259,187	+$158,604	+158%	30 Sep 2023	10-Q	14 Nov 2023	2023	Q3
Q2 2023	$274,040	+$152,690	+126%	30 Jun 2023	10-Q	07 Aug 2023	2023	Q2
Q1 2023	$81,318	-$60,189	-43%	31 Mar 2023	10-Q	12 May 2023	2023	Q1
Q4 2022	$78,700	-$82,372	-51%	31 Dec 2022	10-K	22 Mar 2024	2023	FY
Q3 2022	$100,583	-$63,581	-39%	30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$121,350			30 Jun 2022	10-Q	15 Aug 2022	2022	Q2
Q1 2022	$141,507			31 Mar 2022	10-Q	06 May 2022	2022	Q1
Q4 2021	$161,072			31 Dec 2021	10-K	31 Mar 2023	2022	FY
Q3 2021	$164,164			30 Sep 2021	10-Q	10 Nov 2021	2021	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.